Paul Cox | Investor Relations |
Jeff Jonas | Chief Executive Officer |
Mike Cloonan | Chief Business Officer |
Kimi Iguchi | Chief Financial Officer |
Steve Kanes | Chief Medical Officer |
Jim Doherty | Chief Research Officer |
Brian Abrahams | RBC Capital Markets |
Salveen Richter | Goldman Sachs |
Paul Matteis | Stifel |
Cory Kasimov | JPMorgan |
Akash Tewari | Wolfe Research |
Tazeen Ahmad | Bank of America |
Danielle Brill | Piper Jaffray |
Jay Olson | Oppenheimer |
Marc Goodman | SVB |
Joon Lee | SunTrust |
Gary Nachman | BMO Capital Markets |
Rui Galvao | Ladenburg Thalmann |
Sumant Kulkarni | Canaccord Genuity |
Good morning and welcome to Sage Therapeutics' Fourth Quarter 2018 Financial Results Conference Call. At this time, all participants are in a listen-only mode. This call is being webcast live on the Investors & Media section of Sage's website at sagerx.com. This call is the property of Sage Therapeutics and recording, reproduction or transmission of this call without the express written consent of Sage Therapeutics is strictly prohibited. Please note that this call is being recorded.